“Bis-phossy jaws” – High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw

Abu-Id, 2006, Bisphosphonate-associated osteonecrosis of the jaw, Mund Kiefer Gesichtschir

Adami, 1996, Adverse effects of bisphosphonates. A comparative review, Drug Saf, 14, 158, 10.2165/00002018-199614030-00003

Alkemper, 2005, Osteonecrosis of the jaw associated with the long time use of ‘new’ amino-bisphosphonates by patients with multiple myeloma, Onkologie, 28, 210

Ardine, 2006, Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?, Ann Oncol, 17, 1336, 10.1093/annonc/mdl045

Badros, 2006, Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors, J Clin Oncol, 24, 945, 10.1200/JCO.2005.04.2465

Bagan, 2005, Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases, J Oral Pathol Med, 34, 120, 10.1111/j.1600-0714.2004.00269.x

Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670

Boyce, 1984, Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease, Lancet, 1, 821, 10.1016/S0140-6736(84)92272-4

Capalbo, 2006, Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients, Int J Hematol, 83, 439, 10.1007/BF03006939

Carneiro, 2006, Bisphosphonate-associated mandibular osteonecrosis, AJNR Am J Neuroradiol, 27, 1096

Carter, 2005, Bisphosphonates and avascular necrosis of the jaw: a possible association, Med J Aust, 182, 413, 10.5694/j.1326-5377.2005.tb06761.x

Dannemann, 2006, Clinical experiences with bisphosphonate induced osteochemonecrosis of the jaws, Swiss Med Wkly, 136, 504

Dimitrakopoulos, 2006, Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases, Int J Oral Maxillofac Surg, 10.1016/j.ijom.2006.02.022

Dimopoulos, 2006, Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid, Haematologica, 91, 968

Durie, 2005, Osteonecrosis of the jaw and bisphosphonates, N Engl J Med, 353, 99, 10.1056/NEJM200507073530120

Estilo, 2004, Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study, J Clin Oncol, 22, 747, 10.1200/jco.2004.22.14_suppl.8088

Farrugia, 2006, Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates, Laryngoscope, 116, 115, 10.1097/01.mlg.0000187398.51857.3c

Felsenberg, 1998, Placebo-controlled multicenter study of oral alendronate in postmenopausal osteoporotic women. FOSIT-Study-Group, Maturitas, 31, 35, 10.1016/S0378-5122(98)00050-4

Ficarra, 2005, Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment, J Clin Periodontol, 32, 1123, 10.1111/j.1600-051X.2005.00842.x

Fournier, 2002, Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats, Cancer Res, 62, 6538

Gonzalez-Moles, 2000, Alendronate-related oral mucosa ulcerations, J Oral Pathol Med, 29, 514, 10.1034/j.1600-0714.2000.291006.x

Goodell, 2006, Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports, J Mass Dent Soc, 55, 44

Groetz, 2006, Persisting alveolar sockets-a radiologic symptom of BP-ONJ?, J Oral Maxillofac Surg, 64, 1571, 10.1016/j.joms.2006.05.041

Hay, 2006, Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications, N Z Dent J, 102, 4

Hellstein, 2005, Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?, J Oral Maxillofac Surg, 63, 682, 10.1016/j.joms.2005.01.010

Hess, 1926, The value of elementary phosphorus in rickets, Am J Dis Child, 32, 483, 10.1001/archpedi.1926.04130100003001

Hoefert, 2005, Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates, Mund Kiefer Gesichtschir, 9, 233, 10.1007/s10006-005-0624-6

Hoff, 2006, Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy, J Clin Oncol, 24, 8528, 10.1200/jco.2006.24.18_suppl.8528

Hughes, 1962, Phosphorus necrosis of the jaw: a present-day study, Br J Ind Med, 19, 83

Kademani, 2006, Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy, Mayo Clin Proc, 81, 1100, 10.4065/81.8.1100

Kassowitz, 1884, Die Behandlung der Rachitis mit Phosphor, Ztschrft f klin Med, 7, 36

Katz, 2005, Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases, J Endod, 31, 831, 10.1097/01.don.0000186481.96169.cd

Khamaisi, 2007, Possible association between diabetes and bisphosphonate-related jaw osteonecrosis, J Clin Endocrinol Metab, 92, 1172, 10.1210/jc.2006-2036

Komatsubara, 2004, Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib, J Bone Miner Res, 19, 999, 10.1359/JBMR.040126

Krimmel, 2005, Klinischer Verlauf und Strategien in der Behandlung der Bisphosphonat-induzierten Osteonekrose der Kiefer, Dtsch Zahnärztl Z, 60, A93

Lane, 2005, Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study, J Periodontol, 76, 1113, 10.1902/jop.2005.76.7.1113

Leite, 2006, Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 14, 10.1016/j.tripleo.2005.10.045

Lenz, 2005, Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?, J Craniomaxillofac Surg, 33, 395, 10.1016/j.jcms.2005.07.007

Lugassy, 2004, Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity, Am J Med, 117, 440, 10.1016/j.amjmed.2004.04.015

Maerevoet, 2004, Ten cases of osteonecrosis of the jaws following a treatment by bisphosphonates within the framework of metastasis of breast cancer and multiple myeloma: experience in summer 2004 of a single center, J Clin Oncol, 23, 8271, 10.1200/jco.2005.23.16_suppl.8271

Markiewicz, 2005, Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge, J Am Dent Assoc, 136, 1669, 10.14219/jada.archive.2005.0109

Marunick, 2006, Recent reports link bisphosphonates use to osteonecrosis, Todays FDA, 18, 26

Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1

Marx, 2005, Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010

Mavrokokki, 2007, Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia, J Oral Maxillofac Surg, 65, 415, 10.1016/j.joms.2006.10.061

Melo, 2005, Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition, J Am Dent Assoc, 136, 1675, 10.14219/jada.archive.2005.0110

Melo, 2005, Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy, J Can Dent Assoc, 71, 111

Merigo, 2005, Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report, J Oral Pathol Med, 34, 613, 10.1111/j.1600-0714.2005.00351.x

Migliorati, 2005, Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper, J Am Dent Assoc, 136, 1658, 10.14219/jada.archive.2005.0108

Migliorati, 2005, Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy, Cancer, 104, 83, 10.1002/cncr.21130

Migliorati, 2006, Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment, Lancet Oncol, 7, 508, 10.1016/S1470-2045(06)70726-4

Mignogna, 2006, Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy, J Clin Oncol, 24, 1475, 10.1200/JCO.2005.01.7756

Morris, 2005, Bisphosphonates and jaw osteonecrosis: experience with ibandronate, Eur J Cancer, 372

Nase, 2006, Osteonecrosis of the jaw and oral bisphosphonate treatment, J Am Dent Assoc, 137, 1115, 10.14219/jada.archive.2006.0350

Olson, 2005, Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid, Urology, 66, 658, 10.1016/j.urology.2005.03.028

Ortega, 2006, Jaw complications in breast and prostate cancer patients treated with zoledronic acid, Acta Oncol, 45, 216, 10.1080/02841860500341173

Pastor-Zuazaga, 2006, Osteonecrosis of the jaws and bisphosphonates. Report of three cases, Med Oral Patol Oral Cir Bucal, 11, E76

Peters, 1993, Lingual mandibular sequestration and ulceration, Oral Surg Oral Med Oral Pathol, 75, 739, 10.1016/0030-4220(93)90433-5

Piesold, 2006, Osteonecrosis of the jaws by long term therapy with bisphosphonates, Mund Kiefer Gesichtschir

Pires, 2005, Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy, Oral Dis, 11, 365, 10.1111/j.1601-0825.2005.01130.x

Polizzotto, 2006, Bisphosphonate-associated osteonecrosis of the auditory canal, Br J Haematol, 132, 114, 10.1111/j.1365-2141.2005.05833.x

Pozzi, 2007, Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients, Leuk Lymphoma, 48, 56, 10.1080/10428190600977690

Purcell, 2005, Bisphosphonates and osteonecrosis of the jaw, Med J Aust, 182, 417, 10.5694/j.1326-5377.2005.tb06762.x

Rosen, 2004, Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial, Cancer, 100, 2613, 10.1002/cncr.20308

Ruggiero, 2006, Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, 433, 10.1016/j.tripleo.2006.06.004

Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004

Rühlmann, 2005, Kieferosteomyelitis nach Therapie systemischer osteolytischer Prozesse mit Bisphosphonaten, Quintessenz, 56, 679

Sanna, 2005, Jaw avascular bone necrosis associated with long-term use of biphosphonates, Ann Oncol, 16, 1207, 10.1093/annonc/mdi206

Sarathy, 2005, Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports, J Endod, 31, 759, 10.1097/01.don.0000182737.09980.2c

Schirmer, 2005, Bisphosphonates and osteonecrosis of the jaw, Mund Kiefer Gesichtschir, 9, 239, 10.1007/s10006-005-0616-6

Schwabe, 2005, Mineralstoffpräparate und Osteoporosemittel, 755

Schwartz, 1982, Osteonecrosis of the jaws: a complication of cancer chemotherapy, Head Neck Surg, 4, 251, 10.1002/hed.2890040313

Shlomi, 2005, Avascular necrosis of the jaw bone after bisphosphonate therapy, Harefuah, 144, 536

Soileau, 2006, Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy, J Periodontol, 77, 738, 10.1902/jop.2006.050187

Sonis, 1978, Oral complications in patients receiving treatment for malignancies other than of the head and neck, J Am Dent Assoc, 97, 468, 10.14219/jada.archive.1978.0304

Tarassoff, 2003, Avascular necrosis of the jaws: risk factors in metastatic cancer patients, J Oral Maxillofac Surg, 61, 1238, 10.1016/j.joms.2003.09.001

Thakkar, 2006, Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias, Med Oncol, 23, 51, 10.1385/MO:23:1:51

Tsai, 2006, Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review, Gen Dent, 54, 215

Vannucchi, 2005, Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma, Br J Haematol, 128, 738, 10.1111/j.1365-2141.2005.05382.x

Viale, 2005, Exposed bone in oral cavities, Clin J Oncol Nurs, 9, 355, 10.1188/05.CJON.355-357

Walter, 2006, Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis, Support Care Cancer

Wang, 2003, Osteonecrosis of the jaws associated with cancer chemotherapy, J Oral Maxillofac Surg, 61, 1104, 10.1016/S0278-2391(03)00328-8

Wegner, 1872, Der Einfluss des Phosphors auf den Organismus, Arch Path Anat (Virchows Arch), 55, 11, 10.1007/BF01937197

Whalen, 1973, Pathogenesis of abnormal remodeling of bones: effects of yellow phosphorus in the growing rat, Anat Rec, 177, 15, 10.1002/ar.1091770103

Whyte, 2003, Bisphosphonate-induced osteopetrosis, N Engl J Med, 349, 457, 10.1056/NEJMoa023110

Wutzl, 2006, Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients, Wien Klin Wochenschr, 118, 473, 10.1007/s00508-006-0644-8

Zalavras, 2003, Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis, Crit Rev Eukaryot Gene Expr, 13, 221, 10.1615/CritRevEukaryotGeneExpr.v13.i24.140

Zarychanski, 2006, Osteonecrosis of the jaw associated with pamidronate therapy, Am J Hematol, 81, 73, 10.1002/ajh.20481

Zervas, 2006, Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients, Br J Haematol, 134, 620, 10.1111/j.1365-2141.2006.06230.x